METHOD FOR PROGNOSTICATING PROGRESS OF ERYSIPELAS Russian patent published in 1995 - IPC

FIELD: medicine. SUBSTANCE: this method prescribes determining content of tumoral necrosis factor α in patient's blood serum both in climax of disease and clinical recuperation. If level of tumoral necrosis factor a is found 4 to 5 times lower than initial one, stable remission is prognosticated. If level of tumoral necrosis factor remains the same or builds up, relapse of disease and/or formation of chronic lymphostasis. EFFECT: disclosed method of prognosticating termination of erysipelas in patients suffering from diverse forms of disease by determining level of tumoral necrosis factor a in blood serum is easily reproducible and accurate and characterized by substantial information content, insofar as it employs high-affine monoclonal antibodies in immunoenzymatic tests.